| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 8.19e-11 | 37 | 76 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.00e-10 | 38 | 76 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAMTS2 PRSS12 ADAM5 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-24 ADAM12 | 6.62e-07 | 430 | 76 | 11 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 8.55e-06 | 11 | 76 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.87e-05 | 14 | 76 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 FN1 ANK3 MRPL22 ERVK-8 ERVK-5 ERVK-19 ERVK-7 RIMS1 ERVK-21 ERVK-9 ERVK-24 LTBP4 | 2.87e-05 | 891 | 76 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAMTS2 PRSS12 ADAM5 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-24 ADAM12 | 3.54e-05 | 654 | 76 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 6.71e-05 | 21 | 76 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ADAMTS2 ERVK-8 ERVK-5 RNF216 ERVK-19 ZNF318 ERVK-7 ERVK-21 ERVK-9 ZMIZ1 ERVK-24 | 1.29e-04 | 891 | 76 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 FN1 ADAMTS2 ERVK-8 ERVK-5 OGFOD1 RNF216 ERVK-19 ZNF318 ERVK-7 ERVK-21 ERVK-9 ZMIZ1 ERVK-24 | 1.39e-04 | 1189 | 76 | 14 | GO:0046914 |
| GeneOntologyMolecularFunction | SH3 domain binding | 2.16e-04 | 143 | 76 | 5 | GO:0017124 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.75e-04 | 37 | 76 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.06e-04 | 38 | 76 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 7.15e-04 | 46 | 76 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.32e-03 | 562 | 76 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 KMT2C ANK3 ABI2 TNRC6A POU2AF1 SH2D2A ZMIZ1 MED1 MED13L BCOR MIDEAS | 1.37e-03 | 1160 | 76 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.63e-03 | 61 | 76 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 KMT2C ANK3 ABI2 TNRC6A POU2AF1 SH2D2A ZMIZ1 MED1 MED13L BCOR MIDEAS AHDC1 | 1.70e-03 | 1356 | 76 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.10e-03 | 18 | 76 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | proline-rich region binding | 2.86e-03 | 21 | 76 | 2 | GO:0070064 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.40e-03 | 79 | 76 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | collagen binding | 3.65e-03 | 81 | 76 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 3.74e-03 | 24 | 76 | 2 | GO:0008093 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.91e-03 | 83 | 76 | 3 | GO:1990841 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.68e-07 | 85 | 77 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.68e-07 | 85 | 77 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.01e-06 | 89 | 77 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 VPS37A ERVK-8 ERVK-5 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-24 ZFP36 | 8.59e-06 | 464 | 77 | 10 | GO:0016032 |
| GeneOntologyBiologicalProcess | DNA integration | 1.39e-05 | 13 | 77 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | vitellogenesis | 8.21e-05 | 4 | 77 | 2 | GO:0007296 | |
| Domain | CABIT | 7.80e-05 | 4 | 68 | 2 | PF12736 | |
| Domain | CABIT_dom | 7.80e-05 | 4 | 68 | 2 | IPR025946 | |
| Domain | ZU5 | 4.63e-04 | 9 | 68 | 2 | SM00218 | |
| Domain | ZU5 | 5.77e-04 | 10 | 68 | 2 | PS51145 | |
| Domain | ZU5 | 8.42e-04 | 12 | 68 | 2 | PF00791 | |
| Domain | ZU5_dom | 8.42e-04 | 12 | 68 | 2 | IPR000906 | |
| Domain | ELM2 | 9.93e-04 | 13 | 68 | 2 | PF01448 | |
| Domain | ELM2 | 9.93e-04 | 13 | 68 | 2 | PS51156 | |
| Domain | ELM2_dom | 9.93e-04 | 13 | 68 | 2 | IPR000949 | |
| Domain | ELM2 | 9.93e-04 | 13 | 68 | 2 | SM01189 | |
| Domain | UBA-like | 1.64e-03 | 64 | 68 | 3 | IPR009060 | |
| Domain | zf-CCHC | 3.15e-03 | 23 | 68 | 2 | PF00098 | |
| Domain | SANT_dom | 4.01e-03 | 26 | 68 | 2 | IPR017884 | |
| Domain | AT_hook | 4.32e-03 | 27 | 68 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 4.32e-03 | 27 | 68 | 2 | IPR017956 | |
| Domain | SANT | 4.64e-03 | 28 | 68 | 2 | PS51293 | |
| Domain | FHA | 4.64e-03 | 28 | 68 | 2 | SM00240 | |
| Domain | FHA | 5.67e-03 | 31 | 68 | 2 | PF00498 | |
| Domain | Kringle-like | 6.04e-03 | 32 | 68 | 2 | IPR013806 | |
| Domain | Znf_FYVE-rel | 6.80e-03 | 34 | 68 | 2 | IPR017455 | |
| Domain | ZF_CCHC | 7.19e-03 | 35 | 68 | 2 | PS50158 | |
| Domain | Myb_DNA-binding | 7.19e-03 | 35 | 68 | 2 | PF00249 | |
| Domain | UBA | 7.60e-03 | 36 | 68 | 2 | PF00627 | |
| Domain | FHA_dom | 7.60e-03 | 36 | 68 | 2 | IPR000253 | |
| Domain | - | 7.60e-03 | 36 | 68 | 2 | 2.60.200.20 | |
| Pubmed | 3.90e-11 | 12 | 78 | 5 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 4.22e-11 | 94 | 78 | 8 | 21542922 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.17e-10 | 5 | 78 | 4 | 12629516 | |
| Pubmed | 9.61e-09 | 268 | 78 | 9 | 33640491 | ||
| Pubmed | KMT2C LATS1 ANK3 TJP1 ZNF318 HUWE1 MED1 BCOR UBN2 MIDEAS PRRC2A | 4.11e-08 | 549 | 78 | 11 | 38280479 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.33e-08 | 4 | 78 | 3 | 10469592 | |
| Pubmed | 4.33e-08 | 4 | 78 | 3 | 7983737 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 6.03e-08 | 444 | 78 | 10 | 34795231 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 9.69e-08 | 351 | 78 | 9 | 38297188 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.08e-07 | 5 | 78 | 3 | 11401426 | |
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 15063128 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DDR1 KMT2C ZNF609 VPS37A ANK3 ZNF532 TJP1 SLITRK3 RIMS1 ZMIZ1 HUWE1 UBN2 AHDC1 IL6R TMEM63A | 9.55e-07 | 1489 | 78 | 15 | 28611215 |
| Pubmed | TRERF1 KMT2C ZNF609 ZNF318 MED1 MED13L BCOR UBN2 MIDEAS PRRC2A AHDC1 FOXK1 FOSL1 | 9.99e-07 | 1103 | 78 | 13 | 34189442 | |
| Pubmed | 1.25e-06 | 152 | 78 | 6 | 38360978 | ||
| Pubmed | 1.29e-06 | 10 | 78 | 3 | 12970426 | ||
| Pubmed | ZNF609 ANK3 ABI2 TJP1 ARL13B TNRC6A NHS TNS2 HUWE1 PTPN21 BCOR PRRC2A | 3.70e-06 | 1049 | 78 | 12 | 27880917 | |
| Pubmed | 4.58e-06 | 418 | 78 | 8 | 34709266 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 4.97e-06 | 2 | 78 | 2 | 9460924 | |
| Pubmed | NHS-A isoform of the NHS gene is a novel interactor of ZO-1. | 4.97e-06 | 2 | 78 | 2 | 19447104 | |
| Pubmed | 8.64e-06 | 18 | 78 | 3 | 18664271 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 8.77e-06 | 457 | 78 | 8 | 32344865 | |
| Pubmed | TRERF1 FKBP15 ANK3 ABI2 TJP1 ZNF318 RIMS1 HUWE1 BCOR UBN2 PRRC2A | 9.92e-06 | 963 | 78 | 11 | 28671696 | |
| Pubmed | 1.37e-05 | 486 | 78 | 8 | 20936779 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 32091157 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 10516026 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 9971820 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 21223964 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 29384218 | ||
| Pubmed | Lateral membrane biogenesis in human bronchial epithelial cells requires 190-kDa ankyrin-G. | 1.49e-05 | 3 | 78 | 2 | 14757759 | |
| Pubmed | CFAP91 FN1 ANK3 ZNF532 TJP1 ARL13B RNF216 HUWE1 MED13L CCDC24 PRRC2A ZFP36 | 2.81e-05 | 1285 | 78 | 12 | 35914814 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 35240198 | ||
| Pubmed | The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development. | 2.97e-05 | 4 | 78 | 2 | 17967885 | |
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 24003223 | ||
| Pubmed | 2.97e-05 | 4 | 78 | 2 | 16157329 | ||
| Pubmed | 3.76e-05 | 83 | 78 | 4 | 28794006 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.82e-05 | 167 | 78 | 5 | 20362541 | |
| Pubmed | 4.94e-05 | 5 | 78 | 2 | 23491141 | ||
| Pubmed | MLL4 is required after implantation, whereas MLL3 becomes essential during late gestation. | 5.64e-05 | 33 | 78 | 3 | 32439762 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.92e-05 | 774 | 78 | 9 | 15302935 | |
| Pubmed | Cytoplasmic Cl- couples membrane remodeling to epithelial morphogenesis. | 7.40e-05 | 6 | 78 | 2 | 29229864 | |
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 24928429 | ||
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 9226036 | ||
| Pubmed | 7.40e-05 | 6 | 78 | 2 | 22319020 | ||
| Pubmed | TRERF1 KMT2C ZNF609 MRPL22 TNRC6A ZNF318 ZMIZ1 BCOR UBN2 MIDEAS PRRC2A FOXK1 | 7.81e-05 | 1429 | 78 | 12 | 35140242 | |
| Pubmed | 7.98e-05 | 37 | 78 | 3 | 25742799 | ||
| Pubmed | 8.10e-05 | 101 | 78 | 4 | 10997877 | ||
| Pubmed | Sall1 plays pivotal roles for lens fiber cell differentiation in mouse. | 1.04e-04 | 7 | 78 | 2 | 30929925 | |
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 15509564 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 12093747 | ||
| Pubmed | 1.04e-04 | 7 | 78 | 2 | 9226037 | ||
| Pubmed | ZNF609 LATS1 TJP1 NHS BUD13 HUWE1 MED1 MED13L CDH3 PRRC2A AHDC1 | 1.04e-04 | 1247 | 78 | 11 | 27684187 | |
| Pubmed | 1.38e-04 | 8 | 78 | 2 | 16331648 | ||
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 1.63e-04 | 121 | 78 | 4 | 31900314 | |
| Pubmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. | 1.77e-04 | 9 | 78 | 2 | 28169360 | |
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 34620853 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 21186337 | ||
| Pubmed | 1.77e-04 | 9 | 78 | 2 | 29768210 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | KMT2C FLNC ARSJ GAREM2 HUWE1 MED13L LTBP4 AHDC1 FOXK1 GAREM1 | 1.79e-04 | 1105 | 78 | 10 | 35748872 |
| Pubmed | NEDD4L-mediated Merlin ubiquitination facilitates Hippo pathway activation. | 2.21e-04 | 10 | 78 | 2 | 33058421 | |
| Pubmed | Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development. | 2.21e-04 | 10 | 78 | 2 | 15728677 | |
| Pubmed | 2.21e-04 | 10 | 78 | 2 | 17478428 | ||
| Pubmed | 2.70e-04 | 11 | 78 | 2 | 24348274 | ||
| Pubmed | 2.76e-04 | 56 | 78 | 3 | 22745667 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.84e-04 | 954 | 78 | 9 | 36373674 | |
| Pubmed | 2.91e-04 | 57 | 78 | 3 | 38223760 | ||
| Pubmed | 3.20e-04 | 263 | 78 | 5 | 34702444 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 3.22e-04 | 59 | 78 | 3 | 28813667 | |
| Pubmed | 3.23e-04 | 12 | 78 | 2 | 22072575 | ||
| Pubmed | 3.23e-04 | 12 | 78 | 2 | 20962855 | ||
| Pubmed | 3.23e-04 | 12 | 78 | 2 | 26405179 | ||
| Pubmed | A cell polarity protein aPKClambda is required for eye lens formation and growth. | 3.23e-04 | 12 | 78 | 2 | 19835853 | |
| Pubmed | Retinal pigment epithelial integrity is compromised in the developing albino mouse retina. | 3.23e-04 | 12 | 78 | 2 | 27097562 | |
| Pubmed | 3.23e-04 | 12 | 78 | 2 | 22491404 | ||
| Pubmed | Phospho-tyrosine dependent protein-protein interaction network. | 3.25e-04 | 410 | 78 | 6 | 25814554 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.34e-04 | 146 | 78 | 4 | 23892456 | |
| Pubmed | 3.81e-04 | 13 | 78 | 2 | 18849982 | ||
| Pubmed | A Point Mutation in p190A RhoGAP Affects Ciliogenesis and Leads to Glomerulocystic Kidney Defects. | 3.81e-04 | 13 | 78 | 2 | 26859289 | |
| Pubmed | 3.81e-04 | 13 | 78 | 2 | 27570068 | ||
| Pubmed | mTORC1 signaling and primary cilia are required for brain ventricle morphogenesis. | 3.81e-04 | 13 | 78 | 2 | 27993979 | |
| Pubmed | 3.81e-04 | 13 | 78 | 2 | 23824537 | ||
| Pubmed | 3.81e-04 | 13 | 78 | 2 | 28482867 | ||
| Pubmed | Embryo-uterine interaction coordinates mouse embryogenesis during implantation. | 3.81e-04 | 13 | 78 | 2 | 37522872 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.18e-04 | 430 | 78 | 6 | 35044719 | |
| Pubmed | Blood vessel tubulogenesis requires Rasip1 regulation of GTPase signaling. | 4.44e-04 | 14 | 78 | 2 | 21396893 | |
| Pubmed | 4.44e-04 | 14 | 78 | 2 | 24875170 | ||
| Pubmed | The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. | 4.44e-04 | 14 | 78 | 2 | 22144466 | |
| Pubmed | 4.44e-04 | 14 | 78 | 2 | 32109382 | ||
| Pubmed | 4.44e-04 | 14 | 78 | 2 | 19652092 | ||
| Pubmed | Deletion of astroglial connexins weakens the blood-brain barrier. | 4.44e-04 | 14 | 78 | 2 | 22472609 | |
| Pubmed | 4.44e-04 | 14 | 78 | 2 | 23789091 | ||
| Pubmed | 4.61e-04 | 159 | 78 | 4 | 30581152 | ||
| Pubmed | KMT2C ABI2 TNRC6A BUD13 ZNF318 MED1 BCOR UBN2 PRRC2A AHDC1 FOXK1 | 4.98e-04 | 1497 | 78 | 11 | 31527615 | |
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 5.12e-04 | 15 | 78 | 2 | 30562487 | |
| Pubmed | 5.12e-04 | 15 | 78 | 2 | 23401504 | ||
| Pubmed | 5.12e-04 | 15 | 78 | 2 | 21401944 | ||
| Pubmed | 5.12e-04 | 15 | 78 | 2 | 34419458 | ||
| Pubmed | E3 ubiquitin ligase SIAH1 mediates ubiquitination and degradation of TRB3. | 5.12e-04 | 15 | 78 | 2 | 18276110 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 5.12e-04 | 15 | 78 | 2 | 38871984 | |
| Pubmed | 5.84e-04 | 16 | 78 | 2 | 11564885 | ||
| Interaction | CRX interactions | 2.62e-08 | 254 | 73 | 10 | int:CRX | |
| Interaction | USP54 interactions | 7.22e-08 | 212 | 73 | 9 | int:USP54 | |
| Interaction | TLE3 interactions | TRERF1 ZNF609 ANK3 TNRC6A RNF216 ZNF318 ZMIZ1 BCOR UBN2 MIDEAS AHDC1 | 1.04e-07 | 376 | 73 | 11 | int:TLE3 |
| Interaction | TBR1 interactions | 1.73e-07 | 113 | 73 | 7 | int:TBR1 | |
| Interaction | AR interactions | TRERF1 KMT2C ZNF609 FN1 TJP1 ZNF318 SH2D2A ZMIZ1 HUWE1 MED1 MED13L BCOR UBN2 MIDEAS AHDC1 FOXK1 | 3.94e-07 | 992 | 73 | 16 | int:AR |
| Interaction | EGR2 interactions | 2.85e-06 | 171 | 73 | 7 | int:EGR2 | |
| Interaction | SP7 interactions | 1.40e-05 | 304 | 73 | 8 | int:SP7 | |
| Interaction | ITSN2 interactions | 1.55e-05 | 147 | 73 | 6 | int:ITSN2 | |
| Interaction | AMOT interactions | 1.69e-05 | 312 | 73 | 8 | int:AMOT | |
| Interaction | YWHAH interactions | LATS1 FN1 ABI2 TJP1 STARD9 NCKIPSD NHS TNS2 RIMS1 HUWE1 PTPN21 MED1 ZFP36 FOXK1 | 3.52e-05 | 1102 | 73 | 14 | int:YWHAH |
| Interaction | GATA1 interactions | 3.64e-05 | 171 | 73 | 6 | int:GATA1 | |
| Interaction | TLX1 interactions | 4.14e-05 | 175 | 73 | 6 | int:TLX1 | |
| Interaction | EN1 interactions | 4.94e-05 | 110 | 73 | 5 | int:EN1 | |
| Interaction | PAX8 interactions | 5.16e-05 | 111 | 73 | 5 | int:PAX8 | |
| Interaction | ALG13 interactions | 5.31e-05 | 183 | 73 | 6 | int:ALG13 | |
| Interaction | LHX3 interactions | 5.64e-05 | 185 | 73 | 6 | int:LHX3 | |
| Interaction | ALX3 interactions | 6.68e-05 | 22 | 73 | 3 | int:ALX3 | |
| Interaction | MYOD1 interactions | 7.34e-05 | 194 | 73 | 6 | int:MYOD1 | |
| Interaction | GATA2 interactions | 8.44e-05 | 199 | 73 | 6 | int:GATA2 | |
| Interaction | CELA1 interactions | 8.74e-05 | 24 | 73 | 3 | int:CELA1 | |
| Interaction | FEV interactions | 9.42e-05 | 203 | 73 | 6 | int:FEV | |
| Interaction | CIMIP2B interactions | 9.90e-05 | 25 | 73 | 3 | int:CIMIP2B | |
| Interaction | GCM1 interactions | 1.08e-04 | 68 | 73 | 4 | int:GCM1 | |
| Interaction | PAX9 interactions | 1.09e-04 | 130 | 73 | 5 | int:PAX9 | |
| Interaction | FAM193A interactions | 1.28e-04 | 71 | 73 | 4 | int:FAM193A | |
| Interaction | YAP1 interactions | TRERF1 KMT2C LATS1 ANK3 TJP1 ZFYVE19 ZNF318 HUWE1 PTPN21 MED1 UBN2 MIDEAS PRRC2A | 1.38e-04 | 1095 | 73 | 13 | int:YAP1 |
| Interaction | NUP35 interactions | 1.46e-04 | 424 | 73 | 8 | int:NUP35 | |
| Interaction | SMG7 interactions | 1.55e-04 | 319 | 73 | 7 | int:SMG7 | |
| Interaction | YWHAZ interactions | LATS1 FN1 ABI2 TJP1 STARD9 NCKIPSD ZFYVE19 NHS HUWE1 PTPN21 BCOR PRRC2A FOXK1 GAREM1 | 2.39e-04 | 1319 | 73 | 14 | int:YWHAZ |
| Interaction | SMG5 interactions | 2.46e-04 | 84 | 73 | 4 | int:SMG5 | |
| Interaction | EYA4 interactions | 2.51e-04 | 243 | 73 | 6 | int:EYA4 | |
| Interaction | PAX2 interactions | 2.57e-04 | 85 | 73 | 4 | int:PAX2 | |
| Interaction | NANOG interactions | 3.43e-04 | 481 | 73 | 8 | int:NANOG | |
| Cytoband | 7p22.1 | 6.97e-05 | 47 | 77 | 3 | 7p22.1 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 8.56e-07 | 385 | 70 | 9 | M39264 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.82e-06 | 137 | 70 | 6 | M40313 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.49e-07 | 190 | 70 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.20e-07 | 194 | 70 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 200 | 70 | 6 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.41e-07 | 200 | 70 | 6 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-06 | 154 | 70 | 5 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 7.20e-06 | 170 | 70 | 5 | 9e328e1f904c77dcce8aee4df775d7f0ac725775 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.00e-06 | 178 | 70 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-06 | 181 | 70 | 5 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-06 | 181 | 70 | 5 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 185 | 70 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.09e-05 | 185 | 70 | 5 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 188 | 70 | 5 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 188 | 70 | 5 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 189 | 70 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 190 | 70 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 191 | 70 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-05 | 191 | 70 | 5 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-05 | 191 | 70 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 191 | 70 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 70 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 70 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-05 | 193 | 70 | 5 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.33e-05 | 193 | 70 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | 428b1a3ad87dff7f65de5161d40f102572a9341b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-05 | 193 | 70 | 5 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 193 | 70 | 5 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | PND01|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 193 | 70 | 5 | c291345c11cfcbceacbdc001a5851f67478a2779 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 1.36e-05 | 194 | 70 | 5 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 194 | 70 | 5 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 195 | 70 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-05 | 195 | 70 | 5 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-05 | 196 | 70 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 196 | 70 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 196 | 70 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-05 | 197 | 70 | 5 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.47e-05 | 197 | 70 | 5 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 198 | 70 | 5 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-05 | 198 | 70 | 5 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 198 | 70 | 5 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 199 | 70 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-05 | 199 | 70 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.58e-05 | 200 | 70 | 5 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.58e-05 | 200 | 70 | 5 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.58e-05 | 200 | 70 | 5 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.58e-05 | 200 | 70 | 5 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.58e-05 | 200 | 70 | 5 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.04e-05 | 145 | 70 | 4 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 155 | 70 | 4 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 155 | 70 | 4 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-04 | 157 | 70 | 4 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 169 | 70 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 172 | 70 | 4 | bd73fd3520064d430a153cfdd5c2858b6c184c59 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 172 | 70 | 4 | 47ee78ed3ba6516dad8f12dbf70bca5ed1c60aff | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 174 | 70 | 4 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 174 | 70 | 4 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.68e-04 | 68 | 70 | 3 | a54903d0368e57d62608693d1f6764526d6e38b2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 176 | 70 | 4 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 176 | 70 | 4 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.73e-04 | 177 | 70 | 4 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.77e-04 | 178 | 70 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 178 | 70 | 4 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-04 | 178 | 70 | 4 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 178 | 70 | 4 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 179 | 70 | 4 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.81e-04 | 179 | 70 | 4 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 180 | 70 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 181 | 70 | 4 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 1.89e-04 | 181 | 70 | 4 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.89e-04 | 181 | 70 | 4 | 091e7975badd1ffa463a8ec87908be20781ecfd6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 182 | 70 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 182 | 70 | 4 | ef65b095f4240d61cfd4a59aec19d72d324dba1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 182 | 70 | 4 | 97a805783a1f2b055c21307db250e3688674eff3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-5|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.93e-04 | 182 | 70 | 4 | 9e48d5b634603bc7a8d29290202a311457678328 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.93e-04 | 182 | 70 | 4 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 1.93e-04 | 182 | 70 | 4 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 183 | 70 | 4 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.01e-04 | 184 | 70 | 4 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.01e-04 | 184 | 70 | 4 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 184 | 70 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 184 | 70 | 4 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-04 | 185 | 70 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-04 | 185 | 70 | 4 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-04 | 185 | 70 | 4 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.05e-04 | 185 | 70 | 4 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.05e-04 | 185 | 70 | 4 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-04 | 185 | 70 | 4 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 186 | 70 | 4 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.10e-04 | 186 | 70 | 4 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-NK_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.10e-04 | 186 | 70 | 4 | b099cb0902e9afb11218d70407d3cab212343c6d | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.14e-04 | 187 | 70 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.14e-04 | 187 | 70 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.14e-04 | 187 | 70 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 187 | 70 | 4 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 2.72e-06 | 197 | 71 | 7 | 5312_UP | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.81e-06 | 198 | 71 | 7 | 6889_DN | |
| Disease | stomach cancer (is_implicated_in) | 2.50e-05 | 72 | 69 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | Disorder of eye | 1.41e-04 | 212 | 69 | 5 | C0015397 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.50e-04 | 12 | 69 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 4.82e-04 | 14 | 69 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | cup-to-disc ratio measurement | 5.11e-04 | 430 | 69 | 6 | EFO_0006939 | |
| Disease | amenorrhea, response to antineoplastic agent | 5.55e-04 | 15 | 69 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Manic Disorder | 6.24e-04 | 71 | 69 | 3 | C0024713 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1 measurement | 6.33e-04 | 16 | 69 | 2 | EFO_0008062 | |
| Disease | Manic | 8.21e-04 | 78 | 69 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 8.52e-04 | 79 | 69 | 3 | C0005587 | |
| Disease | Familial aplasia of the vermis | 9.96e-04 | 20 | 69 | 2 | cv:C0431399 | |
| Disease | Anophthalmia-microphthalmia syndrome | 1.10e-03 | 21 | 69 | 2 | cv:C5680330 | |
| Disease | Joubert syndrome 1 | 1.10e-03 | 21 | 69 | 2 | C4551568 | |
| Disease | Neurodevelopmental Disorders | 1.37e-03 | 93 | 69 | 3 | C1535926 | |
| Disease | myocardial infarction | 1.38e-03 | 350 | 69 | 5 | EFO_0000612 | |
| Disease | congestive heart failure (biomarker_via_orthology) | 2.04e-03 | 107 | 69 | 3 | DOID:6000 (biomarker_via_orthology) | |
| Disease | waist-hip ratio | 2.16e-03 | 1226 | 69 | 9 | EFO_0004343 | |
| Disease | Familial aplasia of the vermis | 2.25e-03 | 30 | 69 | 2 | C0431399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNPFILPPRRLPGQY | 1176 | P40145 | |
| KVRPRYSGPAPPPNR | 561 | Q9BRD0 | |
| TYLPRRTPPPVNSPI | 296 | Q6NVV9 | |
| LINNRPGPREPPPYQ | 471 | Q08345 | |
| PRPYRTLQVVPPSDP | 406 | C9J069 | |
| LAPLRPAPQYPHQVP | 886 | O43184 | |
| YRKPLPPLAVPQRPN | 406 | Q3SXY8 | |
| RLSRPPAPPPGDLQY | 151 | Q5TGY3 | |
| SPNEAFRSPPIPYPR | 641 | Q6W2J9 | |
| QRVSPEPPPAPRLTY | 201 | Q9BXT2 | |
| PPNLIPRRPSPYEKT | 1176 | O95450 | |
| SPYRTLEPVRPPVVP | 196 | Q9NYB9 | |
| PPVVPNDYVPSPTRN | 206 | Q9NYB9 | |
| QQPPLPPLPYAGCRR | 6 | Q96K21 | |
| FLQRNPIPQPRLPTP | 466 | Q7Z4T9 | |
| SLTRPPNYFEPPIPR | 241 | Q8N543 | |
| YLPTQQRPPRTRPPP | 46 | P56730 | |
| VPYSQPPATPRPRIS | 2216 | Q8NEZ4 | |
| NPERPSPIQLYSPPF | 1786 | Q71F56 | |
| GTVNRQPPPPYPLTA | 366 | O95835 | |
| VPVRYPPKDPRSNPR | 531 | Q5FYB0 | |
| PVNVTVPSPPPRNPY | 246 | Q9H706 | |
| LQPVRPLYPAPLSQP | 481 | Q5T1M5 | |
| EVPQLRQPYAPPRPG | 1746 | Q14315 | |
| PPPFTPYVPRILNGL | 746 | O94886 | |
| QPPPYTPTPRFRLTF | 1116 | Q7Z6Z7 | |
| NIMRTQVYRPPPPYP | 556 | Q16825 | |
| AVQPPQRPTPAPRLY | 251 | P0CG20 | |
| NLPPPLYYRPVNTVP | 46 | Q6MZM9 | |
| RSDPNLARYPVKPPP | 356 | Q86UR5 | |
| PTAPEQAPAPARPYQ | 6 | Q16633 | |
| APQGRAPYPQPPTRR | 236 | Q9YNA8 | |
| APYPQPPTRRLNPTA | 241 | Q9YNA8 | |
| APQGRAPYPQPPTRR | 236 | P62683 | |
| APYPQPPTRRLNPTA | 241 | P62683 | |
| APQGRAPYPQPPTRR | 236 | P63145 | |
| APYPQPPTRRLNPTA | 241 | P63145 | |
| APYPQPPTVRLNPTA | 241 | Q9HDB9 | |
| APQGRAPYPQPPTRR | 236 | Q7LDI9 | |
| APYPQPPTRRLNPTA | 241 | Q7LDI9 | |
| APQGRAPYPQPPTRR | 236 | P63130 | |
| APYPQPPTRRLNPTA | 241 | P63130 | |
| EPYPQPPTRRLNPTA | 241 | P62685 | |
| APQGRAPYPQPPTRR | 236 | P63126 | |
| APYPQPPTRRLNPTA | 241 | P63126 | |
| APQGRAPYPQPPTRR | 236 | P62684 | |
| APYPQPPTRRLNPTA | 241 | P62684 | |
| PYRPLVLPQALAPAP | 51 | Q14549 | |
| PPYSLGQLVPERPRP | 406 | P08887 | |
| IPQVPFRPLPQPREA | 2246 | Q9H799 | |
| TATPIRHRPRPYPPN | 2156 | P02751 | |
| PASPLRPLYPQISPL | 211 | P85037 | |
| NNRVAYIEFPPPPPL | 3246 | Q12955 | |
| PQPALPQVQIPFPRR | 331 | Q6PJG2 | |
| LCNVLRPPAYSPPRP | 1401 | Q8N2S1 | |
| LPYPPLALPRIPNVR | 86 | Q9H9S5 | |
| NEPQRPPPQYPLLIV | 46 | Q6UWU4 | |
| PTIIPTPMYRPRPAN | 736 | P22223 | |
| LPAPPLEPYLRPRGQ | 261 | Q8N4L8 | |
| TYPQPVPHPQPSIQR | 751 | Q15648 | |
| PQYSPPQPRPGVIRA | 71 | P15407 | |
| IVYPPQLPGEPRRPA | 51 | Q9NWU5 | |
| NVLVPSRPPRNPYDL | 266 | Q75VX8 | |
| PRKPRSRNFQYPQPP | 1011 | Q7Z5M5 | |
| RHRPAPRPKPSNPIY | 266 | Q9NP31 | |
| PPLPAYPPAHSQRRR | 261 | Q6T4R5 | |
| VQERPPSIPLPSPYI | 271 | Q5UE93 | |
| NQPPIAPYQTRPPIP | 356 | O94933 | |
| APYQTRPPIPIICPT | 361 | O94933 | |
| IPPYVDPRLLQGRPP | 726 | P48634 | |
| IPAPYVPPLPNVRVN | 826 | Q9NWF9 | |
| PYQVLSPDATVPRPP | 806 | Q9P2P6 | |
| YQIPLPSSQIPPQPR | 161 | Q9NZQ3 | |
| APQGRAPYPQPPTRR | 236 | P63128 | |
| APYPQPPTRRLNPTA | 241 | P63128 | |
| PRTRPAPYPLPNIRA | 341 | O75333 | |
| VNPVPVYIPNLSPPA | 591 | Q9HCE3 | |
| QPYREPARAEPPAPR | 41 | Q6ZU65 | |
| TEPRAQPGSPPPRYQ | 131 | Q8N413 | |
| RTLPAFQVPYPPRQL | 121 | Q92791 | |
| PPQPVAAPRRLPIFN | 306 | P26651 | |
| ARPIAPAIPPQQIYT | 656 | O15014 | |
| PPYSPQAQPQPIHRI | 896 | Q07157 | |
| EQPIVPRPAPRPTDY | 176 | P54821 | |
| AARIPPNYQGPAIPP | 771 | Q5VUA4 | |
| PQALPRYPREVPPRF | 126 | Q8NDV7 | |
| SPYAQVQRPPRQTPP | 481 | Q63HR2 | |
| PFLPPYPPQEANRSI | 156 | Q8NEZ2 | |
| PQQTYPGPRPQSLPI | 386 | Q9ULJ6 | |
| NRPPRPVPVANYPHS | 496 | Q9ULJ6 | |
| EPPAPAIPSRYQQVP | 191 | Q96PN7 |